Intercept Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012 - 2010
Cash & Equivalents	55.86	92.83	65.65	74.78	43.25	70.01	43.68	32.74	20.02	13.36	Upgrade
Short-Term Investments	435.05	334.98	411.52	582.57	392.91	344.9	645.71	595.31	219.7	131.47	Upgrade
Cash & Cash Equivalents	490.91	427.81	477.17	657.35	436.16	414.92	689.39	628.06	239.72	144.83	Upgrade
Cash Growth	14.75%	-10.34%	-27.41%	50.71%	5.12%	-39.81%	9.77%	161.99%	65.52%	31.43%	Upgrade
Receivables	26.86	28.34	41.55	38.04	25.69	16.5	9.13	0	0	0	Upgrade
Inventory	6.46	7.88	9.03	8.46	7.11	3.48	2.28	0	0	0	Upgrade
Other Current Assets	15.89	43.99	18	17.46	13.46	13.41	7.08	13.64	6.1	2.73	Upgrade
Total Current Assets	540.13	508.02	545.74	721.32	482.43	448.31	707.87	641.69	245.83	147.56	Upgrade
Property, Plant & Equipment	0.99	3.28	6.33	5.2	10.41	16.18	11.3	10.05	5.85	1.67	Upgrade
Other Long-Term Assets	12.6	15.72	28.42	28.37	16.33	19.86	20.09	4.02	2.47	1.08	Upgrade
Total Long-Term Assets	13.58	19.01	34.75	33.57	26.74	36.04	31.39	14.07	8.32	2.75	Upgrade
Total Assets	553.71	527.02	580.49	754.89	509.17	484.35	739.25	655.76	254.15	150.32	Upgrade
Accounts Payable	116.98	103.78	171.04	153.97	105.11	94.78	65.55	45.59	13.46	7.26	Upgrade
Deferred Revenue	0	0	0	0	2.43	4.45	10.15	8.02	9.8	10.54	Upgrade
Current Debt	109.57	0	0	0	0	0	0	0	0	0	Upgrade
Other Current Liabilities	3.53	64.38	8.04	8.04	6.66	4.8	2.81	-6.24	-8.02	-8.92	Upgrade
Total Current Liabilities	230.08	168.16	179.08	162.01	114.21	104.03	78.51	47.37	15.24	8.88	Upgrade
Long-Term Debt	223.1	539.78	560.58	532.08	371.25	355.68	341.36	0	0	0	Upgrade
Other Long-Term Liabilities	7.45	3.04	7.68	9.25	4.58	8.25	4.45	6.24	8.02	59.03	Upgrade
Total Long-Term Liabilities	230.56	542.82	568.27	541.33	375.83	363.93	345.81	6.24	8.02	59.03	Upgrade
Total Liabilities	460.63	710.99	747.34	703.33	490.04	467.96	424.32	53.61	23.26	67.91	Upgrade
Total Debt	332.67	539.78	560.58	532.08	371.25	355.68	341.36	0	0	0	Upgrade
Debt Growth	-38.37%	-3.71%	5.36%	43.32%	4.38%	4.20%	-	-	-	-	Upgrade
Common Stock	2,238	2,309	2,234	2,176	1,800	1,487	1,426	1,300	700.38	268.32	Upgrade
Retained Earnings	-2,136.89	-2,489.77	-2,398.35	-2,123.47	-1,778.79	-1,469.54	-1,108.46	-695.63	-469.2	-185.98	Upgrade
Comprehensive Income	-8.26	-2.87	-2.48	-1.14	-2.26	-0.79	-2.8	-2.25	-0.28	0.06	Upgrade
Shareholders' Equity	93.08	-183.96	-166.85	51.56	19.13	16.39	314.93	602.15	230.89	82.41	Upgrade
Net Cash / Debt	158.24	-111.97	-83.41	125.27	64.91	59.24	348.03	628.06	239.72	144.83	Upgrade
Net Cash / Debt Growth	-	-	-	92.99%	9.57%	-82.98%	-44.59%	161.99%	65.52%	31.43%	Upgrade
Net Cash Per Share	4.68	-3.51	-2.53	3.96	2.28	2.36	14.11	26.51	11.53	8.03	Upgrade
Working Capital	310.05	339.86	366.67	559.31	368.22	344.27	629.35	594.32	230.59	138.68	Upgrade
Book Value Per Share	2.75	-5.77	-5.06	1.63	0.67	0.65	12.77	25.41	11.11	4.57	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).